Search This Blog

Tuesday, May 7, 2013

DEA Report on Arena Pharma Drug Belviq

The DEA has come out with their report on Arena's drug Belviq. The information is attached here.

The stock has risen on the news and is now priced at $8.37 on 2 X volume.

Previous covered call trades have been made in AA, OCZ, YHOO, ZAGG, LLEN, CLSN, EDMC, EXAS, ARIA

If you are interested in futures options or futures etf options, Sell The Call is now following Trading Futures ETF Options.

** Disclaimer** - Sell The Call is simply posting information. This is not a recommendation to buy or sell any of the securities above. Do your due diligence before investing as there is risk to all investments. Be sure to Like ourFacebook page, and follow Sell The Call's Twitter and Stocktwits pages.  

No comments:

Post a Comment